A site where you can find recommended contractors for non-clinical testing｜effical " Non-Clinical CROs and Agencies " FUJIFILM Wako Pure Chemical Corporation

FUJIFILM Wako Pure Chemical Corporation

Table of Contents

FUJIFILM Wako Pure Chemical Corporation is a provider of GLP-compliant safety studies based in Medford, with extensive experience in non-clinical testing. This section introduces the company’s features in non-clinical studies, examples of disease models, and case studies. We hope you can use this information as a reference when selecting a reliable partner for your non-clinical studies.

Features of FUJIFILM Wako Pure Chemical Corporation’s Contract Non-Clinical Study Services

Comprehensive pharmacological studies across a wide range of disease areas

FUJIFILM Wako Pure Chemical Corporation provides pharmacological efficacy studies covering a broad spectrum of disease areas, including the neurology, cardiovascular, metabolic, and respiratory, digestive system, renal and urinary systems, allergy, inflammation, immune systems, and immuno oncology. The company also offers in vitro Magnus assays to accommodate diverse testing needs for different drug development stages. They are GLP compliant; offering comprehensive support throughout early discovery to later drug development.

Pharmacokinetic studies compliant with GLP and reliability standards

FUJIFILM Wako Pure Chemical Corporation has established a robust platform for pharmacokinetic (PK) studies with Good Laboratory Practice (GLP) and reliability standards. They offer in vivo study for absorption, distribution, metabolism, and excretion (ADME) of drug candidates. They thrive to deliver precise pharmacokinetic data to support each stage of drug development and ensure smooth transition to clinical stage.

High-quality safety studies backed by advanced analytical technologies

The company also provide high-quality safety /toxicity study and mutagenicity study. You can determine initial human doses and safe dose ranges by clarifying target organs, dose dependency, exposure relationships, and recovery potential. Leveraging analytical and bio-related technologies cultivated over many years, they offer in vivo study and a wide range of analytical service.

3 Specialized Pre-clinical CROs for Advanced Drug Discovery

Contract Research Partners with FUJIFILM Wako Pure Chemical Corporation

Kamakura Techno-Science Co., Ltd.

Kamakura Techno-Science is a contract research organization who provides safety and pharmacological evaluations. They utilize bio-related technologies developed in Toray’s life science business. The company conducts a wide variety of studies in neurological, cardiovascular, metabolic, respiratory, gastrointestinal, renal/urinary, and allergic, inflammatory,and autoimmune related.

Fukushima Cell Factory Co., Ltd.

Fukushima Cell Factory offers research support services for drug development by utilizing technologies and expertise cultivated through the Fukushima Pharmaceutical Industry Support Project. Services include cell and specimen storage, cell culture, cell characterization, and cell sorting.

Non-Clinical Model at FUJIFILM Wako Pure Chemical Corporation

In vitro (ex vivo) study using F-PDX® (Patient-Derived Tumor Xenograft)

Fukushima Pharmaceutical Industry has developed Tumor-bearing animal model that maintains original tumor’s histopathology and gene expression characteristics. This model is suited for evaluating immuno-oncology indications by transplanting the PDX into immunodeficient mice. Ex vivo testing is also available without transplantation, enabling direct evaluation of drug efficacy.

Reference: FUJIFILM Wako Pure Chemical Corporation official websitehttps://labchem-wako.fujifilm.com/jp/custom_service/products/95178.html

Pharmacological study using cerebral infarction (cerebral ischemia) models

This model is induced by cerebral ischemia with middle cerebral artery occlusion and bilateral common carotid artery ligation. Rats are used, and reports are typically delivered within one month.

Reference: FUJIFILM Wako Pure Chemical Corporation official websitehttps://labchem-wako.fujifilm.com/jp/custom_service/products/95208.html

Company Information

FUJIFILM Wako Pure Chemical Corporation offers a wide range of development support services, including drug discovery, regenerative medicine, and gene therapy.

Address	3-1-2 Dosho-machi, Chuo-ku, Osaka, Japan
Tel	06-6203-3741
Website	https://www.fujifilm.com/ffwk/ja

3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation

SMC Laboratories, Inc.

Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)

SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.
With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.

Consult study design and disease model development
with SMC Laboratories, Inc.

Consult SMC Laboratories
Call us

Safety Studies
Comprehensive Safety Evaluation for FIH Applications

Labcorp Holdings Inc.
(Labcorp Drug Development)

Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)

Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.

Consult Labcorp Holdings Inc.
Discuss GLP/ICH-compliant study design for your FIH submission.

To labcorp.
Call us

Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation

PhoenixBio Co., Ltd.

Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)

PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.
The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus

Phoenix Bio.
Call us